JSC
LLY icon

Jackson Square Capital’s Eli Lilly LLY Stock Holding History

Jackson Square Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Buy
18,563
+126
+0.7% +$128K 3.58% 6
2025
Q4 		$19.8M Buy
18,437
+3,875
+27% +$3.71M 3.92% 7
2025
Q3 		$11.1M Sell
14,562
-5,749
-28% -$4.28M 2.42% 9
2025
Q2 		$15.8M Buy
20,311
+1,149
+6% +$893K 3.52% 5
2025
Q1 		$15.8M Sell
19,162
-38
-0.2% -$31.6K 5.15% 3
2024
Q4 		$14.8M Sell
19,200
-3,677
-16% -$3.04M 3.57% 6
2024
Q3 		$20.3M Sell
22,877
-1,318
-5% -$1.18M 5.03% 4
2024
Q2 		$21.9M Buy
24,195
+112
+0.5% +$89.6K 5.39% 4
2024
Q1 		$18.7M Buy
24,083
+35
+0.1% +$24.9K 4.82% 4
2023
Q4 		$14M Sell
24,048
-101
-0.4% -$59K 4.51% 3
2023
Q3 		$13M Buy
24,149
+486
+2% +$250K 5.21% 3
2023
Q2 		$11.1M Sell
23,663
-2,095
-8% -$879K 4.46% 3
2023
Q1 		$8.85M Buy
25,758
+2,049
+9% +$691K 3.96% 4
2022
Q4 		$8.67M Sell
23,709
-675
-3% -$239K 4.08% 2
2022
Q3 		$7.88M Sell
24,384
-645
-3% -$204K 3.85% 4
2022
Q2 		$8.12M Buy
25,029
+548
+2% +$164K 3.43% 4
2022
Q1 		$7.01M Buy
24,481
+1,813
+8% +$467K 2.19% 9
2021
Q4 		$6.26M Buy
22,668
+492
+2% +$125K 1.8% 13
2021
Q3 		$5.12M Sell
22,176
-36
-0.2% -$8.88K 1.67% 18
2021
Q2 		$5.1M Sell
22,212
-276
-1% -$55.4K 1.64% 21
2021
Q1 		$4.2M Buy
22,488
+4,340
+24% +$849K 1.6% 21
2020
Q4 		$3.06M Sell
18,148
-2,524
-12% -$377K 1.18% 32
2020
Q3 		$3.06M Buy
20,672
+932
+5% +$144K 1.35% 28
2020
Q2 		$3.24M Buy
19,740
+8,234
+72% +$1.26M 1.64% 24
2020
Q1 		$1.6M Buy
11,506
+1,586
+16% +$218K 1.24% 31
2019
Q4 		$1.3M Buy
+9,920
New +$1.15M 0.75% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jackson Square Capital's LLY Position: Q1 2026 in Review

Jackson Square Capital increased its Eli Lilly (LLY) stake by 0.68% in Q1 2026, buying an estimated $128K and bringing the position to 18,563 shares worth $17.1M. The position accounts for 3.58% of the portfolio, ranked #6.

Jackson Square Capital first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $21.9M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jackson Square Capital held 18,563 shares of Eli Lilly worth $17.1M as of Q1 2026.
  • Jackson Square Capital bought 126 Eli Lilly shares in Q1 2026, an estimated $128K.
  • Eli Lilly made up 3.58% of Jackson Square Capital's portfolio in Q1 2026, its #6 holding.
  • Jackson Square Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Jackson Square Capital's Eli Lilly position peaked at $21.9M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jackson Square Capital's 13F filing for Q1 2026, filed 13 Apr 2026.